Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis Condition: Progressive Multiple SclerosisInterventions: Drug: Placebo; Drug: Masitinib (4.5)Sponsor: AB ScienceRecruiting Author: